These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35935843)

  • 1. Comparison of the efficiency of anti-VEGF drugs intravitreal injections treatment with or without retinal laser photocoagulation for macular edema secondary to retinal vein occlusion: A systematic review and meta-analysis.
    Zou W; Du Y; Ji X; Zhang J; Ding H; Chen J; Wang T; Ji F; Huang J
    Front Pharmacol; 2022; 13():948852. PubMed ID: 35935843
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination intravitreal anti-vascular endothelial growth factor inhibitors and macular laser photocoagulation relative to intravitreal injection monotherapy in macular oedema secondary to retinal vein occlusion: a meta-analysis of randomized controlled trials.
    Bhambra N; Sayal AP; Popovic MM; Muni RH; Kertes PJ
    Eye (Lond); 2022 Dec; 36(12):2271-2278. PubMed ID: 34819660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photocoagulation or sham laser in addition to conventional anti-VEGF therapy in macular edema associated with TelCaps due to diabetic macular edema or retinal vein occlusion (TalaDME): a study protocol for a multicentric, French, two-group, non-commercial, active-control, observer-masked, non-inferiority, randomized controlled clinical trial.
    Dupas B; Castro-Farias D; Girmens JF; Eginay A; Couturier A; Villeroy F; Delyfer MN; Creuzot-Garcher C; Giocanti-Auregan A; Béral L; Arndt C; Mesnard C; Vicaut E; Chaumet-Riffaud P; Durand-Zaleski I; Paques M
    Trials; 2024 Apr; 25(1):273. PubMed ID: 38649937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and meta-analysis to compare the efficacy of conbercept with ranibizumab in patients with macular edema secondary to retinal vein occlusion.
    Liu W; Li Y; Cao R; Bai Z; Liu W
    Medicine (Baltimore); 2020 May; 99(21):e20222. PubMed ID: 32481293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and effectiveness of anti-VEGF or steroids monotherapy versus combination treatment for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.
    Zhang W; Liu Y; Sang A
    BMC Ophthalmol; 2022 Dec; 22(1):472. PubMed ID: 36474156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ischemia and laser photocoagulation in retinal vein occlusion].
    Rehak M; Storch MW; Hattenbach LO; Feltgen N
    Ophthalmologie; 2022 Nov; 119(11):1121-1128. PubMed ID: 36357589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report.
    Feng XX; Li C; Shao WW; Yuan YG; Qian XB; Zheng QS; Li YJ; Gao QY
    Int J Ophthalmol; 2018; 11(3):429-437. PubMed ID: 29600177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial.
    Song S; Yu X; Zhang P; Gu X; Dai H
    BMC Ophthalmol; 2020 Jun; 20(1):241. PubMed ID: 32560639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions.
    Ivanovska Adjievska B; Boskurt S; Orovcanec N; Dimovska-Jordanova V
    Clin Ophthalmol; 2017; 11():1183-1190. PubMed ID: 28790803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Efficacy of Pharmacotherapy for Macular Edema Secondary to Retinal Vein Occlusion: A Network Meta-analysis.
    Gao S; Zhang Y; Li X; Ge G; Duan J; Lei C; Zeng Y; Cai Z; Zhang M
    Front Pharmacol; 2021; 12():752048. PubMed ID: 34955825
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.
    Hu Q; Li H; Xu W; Du Y; Ma C; He J
    Indian J Ophthalmol; 2019 Nov; 67(11):1800-1809. PubMed ID: 31638037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z; Mahroo O; Bunce C; Mitry D
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
    Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
    Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.
    Lu Y; Su L; Xu X
    J Ocul Pharmacol Ther; 2013 Oct; 29(8):702-8. PubMed ID: 23746130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
    Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
    Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between anti-VEGF therapy and corticosteroid or laser therapy for macular oedema secondary to retinal vein occlusion: A meta-analysis.
    Qian T; Zhao M; Xu X
    J Clin Pharm Ther; 2017 Oct; 42(5):519-529. PubMed ID: 28639290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.